Bulk Manufacturer of Controlled Substances Application: Eli Elsohly Laboratories, 63142 [2020-22068]

Download as PDF 63142 Federal Register / Vol. 85, No. 194 / Tuesday, October 6, 2020 / Notices Wildlife Laboratories, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before November 5, 2020. Such persons may also file a written request for a hearing on the application on or before November 5, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on September 4, 2020, Wildlife Laboratories, LLC, 1230 W Ash Street, Unit D, Windsor, Colorado 80550–4677, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUMMARY: Controlled substance Drug code Etorphine HCL ................ Thiafentanil ..................... 9059 9729 Schedule II II The company plans to import the listed controlled substances for distribution to its customers. No other activity for these drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA-approved or nonapproved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator. [FR Doc. 2020–22069 Filed 10–5–20; 8:45 am] ACTION: Notice of application. Eli Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 7, 2020. Such persons may also file a written request for a hearing on the application on or before December 7, 2020. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: BILLING CODE P In accordance with 21 CFR 1301.33(a), this is notice that on August 17, 2020, Eli Elsohly Laboratories, 5 Industrial Park Drive, Oxford, Mississippi 38655, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–722] Bulk Manufacturer of Controlled Substances Application: Eli Elsohly Laboratories Drug Enforcement Administration, Justice. AGENCY: Controlled substances Drug code khammond on DSKJM1Z7X2PROD with NOTICES Marihuana Extract ........................................................................................................................................................... Marihuana ........................................................................................................................................................................ Tetrahydrocannabinols .................................................................................................................................................... Dihydromorphone ............................................................................................................................................................ Amphetamine ................................................................................................................................................................... Methamphetamine ........................................................................................................................................................... Cocaine ............................................................................................................................................................................ Codeine ........................................................................................................................................................................... Dihydrocodeine ................................................................................................................................................................ Oxycodone ....................................................................................................................................................................... Hydromorphone ............................................................................................................................................................... Ecgonine .......................................................................................................................................................................... Hydrocodone ................................................................................................................................................................... Morphine .......................................................................................................................................................................... Thebaine .......................................................................................................................................................................... Oxymorphone .................................................................................................................................................................. The company plans to manufacture the listed controlled substances for product development and reference standards. In reference to drug codes 7360 (marihuana) and 7370 (THC), the company plans to isolate these controlled substances from procured 7350 (marihuana extract). In reference to drug code 7360, no cultivation activities are authorized for this registration. No VerDate Sep<11>2014 17:52 Oct 05, 2020 Jkt 253001 other activities for these drug codes are authorized for this registration. [FR Doc. 2020–22068 Filed 10–5–20; 8:45 am] PO 00000 I I I I II II II II II II II II II II II II DEPARTMENT OF JUSTICE Federal Bureau of Investigation William T. McDermott, Assistant Administrator. BILLING CODE P 7350 7360 7370 9145 1100 1105 9041 9050 9120 9143 9150 9180 9193 9300 9333 9652 Schedule Meeting of the Compact Council for the National Crime Prevention and Privacy Compact Federal Bureau of Investigation, Department of Justice. AGENCY: Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\06OCN1.SGM 06OCN1

Agencies

[Federal Register Volume 85, Number 194 (Tuesday, October 6, 2020)]
[Notices]
[Page 63142]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22068]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-722]


Bulk Manufacturer of Controlled Substances Application: Eli 
Elsohly Laboratories

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Eli Elsohly Laboratories has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before December 7, 
2020. Such persons may also file a written request for a hearing on the 
application on or before December 7, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 17, 2020, Eli Elsohly Laboratories, 5 
Industrial Park Drive, Oxford, Mississippi 38655, applied to be 
registered as an bulk manufacturer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
       Controlled substances            Drug code          Schedule
------------------------------------------------------------------------
Marihuana Extract..................            7350  I
Marihuana..........................            7360  I
Tetrahydrocannabinols..............            7370  I
Dihydromorphone....................            9145  I
Amphetamine........................            1100  II
Methamphetamine....................            1105  II
Cocaine............................            9041  II
Codeine............................            9050  II
Dihydrocodeine.....................            9120  II
Oxycodone..........................            9143  II
Hydromorphone......................            9150  II
Ecgonine...........................            9180  II
Hydrocodone........................            9193  II
Morphine...........................            9300  II
Thebaine...........................            9333  II
Oxymorphone........................            9652  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
for product development and reference standards. In reference to drug 
codes 7360 (marihuana) and 7370 (THC), the company plans to isolate 
these controlled substances from procured 7350 (marihuana extract). In 
reference to drug code 7360, no cultivation activities are authorized 
for this registration. No other activities for these drug codes are 
authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-22068 Filed 10-5-20; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.